Fol. Biol. 2005, 51, 109-113
https://doi.org/10.14712/fb2005051040109
Immunogenicity and Protective Effect of a DNA Construct Encoding Certain Neutralizing Epitopes of Herpes Simplex Virus Type-1 Glycoprotein B
References
1. 2000) Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine. Vaccine 18, 2132-2141.
< , L., Rodriguez, F., Harkins, S., Zhang, I., Whitton, J. L. (https://doi.org/10.1016/S0264-410X(99)00546-0>
2. 2002) Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunization with herpes simplex virus type 1 genes specifying glycoproteins gB and gD. J. Med. Microbiol. 51, 350-357.
< , A., Chouljenko, V. N., Dauvergne, O., Newman, M. J., Baghian, S., Kousovias, K. G. (https://doi.org/10.1099/0022-1317-51-4-350>
3. 1999) Herpes simplex virus vaccines. Vaccine 17, 1681-1689.
< , D., Stanbery, L. (https://doi.org/10.1016/S0264-410X(98)00434-4>
4. 1991) Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66, 1145-1153.
< , M., Schlicht, H., Ruppert, T., Reddehase, M. J., Koszinowski, U. H. (https://doi.org/10.1016/0092-8674(91)90037-Y>
5. 2001) Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection. Vaccine 19, 1225-1231.
, E., Balboni, P. G., Incorvaia, C., Arnani, R., Parmeggiani, F., Cassai, E. (
6. 1999) Expression of herpes simplex virus glycoprotein B in insect cells. Virus Res. 22, 23-39.
, H., Kaiwer, R., Nesburn, A., Wechsler, S. L. (
7. 1984) Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity. J. Virol. 50, 805-812.
< , J., Schroder, C. H., Kumel, G., Szczesiul, M., Levine, M. (https://doi.org/10.1128/jvi.50.3.805-812.1984>
8. 1991) Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vector and synthetic peptides. J. Virol. 65, 1177-1186.
< , T., Graham, F., Rosenthal, K. L., Johnson, D. C. (https://doi.org/10.1128/jvi.65.3.1177-1186.1991>
9. 2000) Plasmid DNA-expressing secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses. J. Infect. Dis. 182, 1311-20.
< , T. J., Herold, K. M., Arnold, R. L., McElhiney, S. P., Shroff, K. E., Pachuk, C. J. (https://doi.org/10.1086/315879>
10. 1991) Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J. Virol. 184, 253-264.
, S., Cai, W., Person, S., Levine, M., Glorioso, J. C. (
11. 1999) The epidemiology of uncommon herpes simplex virus type 1 infections. Herpes 6, 16-19.
, Y., Spruance, S. (
12. 1995) Genetic immunization against herpes simplex virus. J. Immunol. 155, 259-265.
< , E., Rouse, R., Zhiya, Y., Wire, W. S., Rouse, B. T. (https://doi.org/10.4049/jimmunol.155.1.259>
13. 1996) Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA 93, 11414-11420.
< , W. L., Armstong, M. E., Keys, R. D., Liu, M. A., (https://doi.org/10.1073/pnas.93.21.11414>
14. 2000) Immunity induced by DNA immunization with herpes simplex virus type 2 glycoprotein B and C. Vaccine 18, 875-883.
< , J. C., Twomey, T. A., Tepe, E. T., Bernstein. D. I. (https://doi.org/10.1016/S0264-410X(99)00325-4>
15. 1999) Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro. J. Virol. 73, 5934-5944.
< , Z., Sanna, P. P., Cunningham, A. L. (https://doi.org/10.1128/JVI.73.7.5934-5944.1999>
16. 1991) A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum. Virology 184, 253-264.
< , D., Quadri, I., Pereira, L. (https://doi.org/10.1016/0042-6822(91)90842-Y>
17. 1992) Domains of herpes simplex virus 1 glycoprotein B that function in virus penetration, cell to cell spread and cell fusion. Virology 186, 99-112.
< , D., Paz, P., Pereira, L. (https://doi.org/10.1016/0042-6822(92)90064-V>
18. 1989) Domain structure of herpes simplex virus type 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 178, 11-24.
< , P., Ali, M., Kousoulas, K., Bin, H., Banks, T. (https://doi.org/10.1016/0042-6822(89)90102-5>
19. 1999) Mutations in conformation-dependent domain of herpes simplex virus type 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule. Virology 180, 135-152.
< , I., Gimeno, C., Navarro, D., Pereira, L. (https://doi.org/10.1016/0042-6822(91)90017-6>
20. 1998) DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72, 5147-5181.
, F., An, L., Harkins, S., Zhang, J., Yokoyama, M., Widera, G. (
21. Roizman, B., Knipe, D. M. (2001) Herpes simplex viruses and their replication. In: Fields Virology, eds. Knipe, D. M., Howley, P. M., pp. 2391-2510, Lippincott Williams & Wilkins, Philadelphia.
22. 1992) Epitopes of herpes simplex virus glycoprotein B that bind type-common neutralizing antibodies elicit typespecific antibody-dependent cellular cytotoxicity. J. Infect. Dis. 166, 623-627.
< , L., Paz, P., Navarro, D., Pereira, L., Kohl, S. (https://doi.org/10.1093/infdis/166.3.623>
23. 1996) Herpes immunization ñ on the threshold. J. Eur. Acad. Dermatol. Venereol. 7, 120-128.
, L. R. (
24. 2000) Prospects for control of herpes simplex virus disease through immunization. Clin. Infect. Dis. 30, 549-566.
< , L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aok, F. Y., et al. (https://doi.org/10.1086/313687>
25. 1999) The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73, 7619-7626.
< , M., Keating, R., Health, W., Carbone, F. R. (https://doi.org/10.1128/JVI.73.9.7619-7626.1999>
26. 1998) Protection by minigenes: a novel approach of DNA vaccines. Vaccine 16, 1660-1667.
, Z., Karem, K. L., Kanangat, S., Manickan, E., Rouse, B. T. (